Get the Stockscreener App
14.53
9.47%
-1.52
After Hours:
14.74
0.21
+1.45%
Overview
News
Price History
Option Chain
Financials
Why FMC Down?
Discussions
Forecast
Stock Split
Dividend History
Fmc Corp stock is traded at $14.53, with a volume of 4.72M.
It is down -9.47% in the last 24 hours and down -4.09% over the past month.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
See More
Previous Close:
$16.05
Open:
$15.96
24h Volume:
4.72M
Relative Volume:
1.00
Market Cap:
$1.82B
Revenue:
$4.17B
Net Income/Loss:
$1.46B
P/E Ratio:
1.2504
EPS:
11.62
Net Cash Flow:
$493.00M
1W Performance:
+6.29%
1M Performance:
-4.09%
6M Performance:
-58.66%
1Y Performance:
-60.37%
1-Day Range:
$14.39
$16.24
1-Week Range:
$13.27
$16.75
52-Week Range:
$12.17
$44.78
Fmc Corp Stock (FMC) Company Profile
Name
Fmc Corp
Sector
Industry
Phone
215-299-6668
Address
2929 WALNUT STREET, PHILADELPHIA, PA
Compare FMC vs CTVA, NTR, CF, MOS, ICL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FMC
Fmc Corp
|
14.53 | 2.00B | 4.17B | 1.46B | 493.00M | 11.62 |
|
CTVA
Corteva Inc
|
74.11 | 50.63B | 17.40B | 1.20B | 2.82B | 1.5836 |
|
NTR
Nutrien Ltd
|
70.43 | 35.32B | 26.62B | 1.84B | 2.16B | 3.711 |
|
CF
Cf Industries Holdings Inc
|
94.16 | 15.12B | 6.74B | 1.70B | 1.71B | 8.2952 |
|
MOS
Mosaic Company
|
29.77 | 9.88B | 11.06B | 367.80M | 212.50M | 1.16 |
|
ICL
Icl Group Ltd
|
5.73 | 7.42B | 6.84B | 407.00M | 755.00M | 0.32 |
Fmc Corp Stock (FMC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Nov-11-25 | Resumed | Wells Fargo | Equal Weight |
| Oct-31-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-31-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-14-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Jun-23-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-25-25 | Upgrade | Mizuho | Neutral → Outperform |
| Mar-13-25 | Initiated | Goldman | Buy |
| Feb-14-25 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Feb-07-25 | Downgrade | UBS | Buy → Neutral |
| Feb-05-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-21-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-14-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-23-24 | Initiated | Citigroup | Neutral |
| Jun-26-24 | Initiated | Barclays | Equal Weight |
| Mar-01-24 | Initiated | Wolfe Research | Peer Perform |
| Feb-12-24 | Downgrade | Loop Capital | Buy → Hold |
| Feb-07-24 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Jan-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-04-24 | Initiated | ROTH MKM | Buy |
| Dec-14-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-07-23 | Downgrade | Mizuho | Buy → Neutral |
| Oct-24-23 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-24-23 | Downgrade | Goldman | Buy → Neutral |
| Oct-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-16-23 | Upgrade | Vertical Research | Hold → Buy |
| Sep-25-23 | Downgrade | Redburn Atlantic | Overweight → Neutral |
| Sep-05-23 | Downgrade | UBS | Buy → Neutral |
| Aug-21-23 | Initiated | JP Morgan | Neutral |
| Aug-04-23 | Upgrade | Credit Suisse | Underperform → Neutral |
| Jul-24-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-17-23 | Upgrade | Redburn | Neutral → Buy |
| Jan-19-23 | Resumed | Wells Fargo | Overweight |
| Jan-10-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-15-22 | Upgrade | Loop Capital | Hold → Buy |
| Jul-20-22 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jun-21-22 | Upgrade | BofA Securities | Underperform → Buy |
| Jun-13-22 | Downgrade | Redburn | Buy → Neutral |
| May-31-22 | Initiated | Credit Suisse | Underperform |
| Apr-14-22 | Downgrade | Loop Capital | Buy → Hold |
| Mar-31-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| Mar-22-22 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-22 | Reiterated | Citigroup | Buy |
| Feb-10-22 | Reiterated | Mizuho | Buy |
| Feb-10-22 | Reiterated | Monness Crespi & Hardt | Buy |
| Feb-10-22 | Reiterated | Wells Fargo | Overweight |
| Jan-31-22 | Initiated | Redburn | Buy |
| Jan-11-22 | Upgrade | Citigroup | Neutral → Buy |
| Nov-29-21 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-18-21 | Upgrade | Loop Capital | Hold → Buy |
| Oct-13-21 | Initiated | Mizuho | Buy |
| Oct-11-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-24-21 | Downgrade | Vertical Research | Buy → Hold |
| May-06-21 | Downgrade | Citigroup | Buy → Neutral |
| Feb-11-21 | Upgrade | Monness Crespi & Hardt | Neutral → Buy |
| Sep-17-20 | Initiated | UBS | Buy |
| Mar-26-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Mar-13-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Oct-16-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-16-19 | Initiated | Wells Fargo | Outperform |
| Sep-18-19 | Initiated | Exane BNP Paribas | Outperform |
| Aug-09-19 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-02-19 | Upgrade | Goldman | Neutral → Buy |
| Aug-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-13-19 | Resumed | Citigroup | Buy |
| May-20-19 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-18-19 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-21-19 | Reiterated | Jefferies | Buy |
| Mar-08-19 | Resumed | Goldman | Neutral |
| Nov-14-18 | Initiated | Buckingham Research | Buy |
| Nov-09-18 | Resumed | Loop Capital | Buy |
| Nov-05-18 | Resumed | Citigroup | Buy |
| Nov-05-18 | Resumed | Credit Suisse | Outperform |
| May-14-18 | Upgrade | Goldman | Neutral → Buy |
| May-04-18 | Upgrade | Stephens | Equal-Weight → Overweight |
View All
Fmc Corp Stock (FMC) Latest News
FMC Posts $2.2 Billion Loss, Launches Strategic Review Including Possible Sale - PHILADELPHIA.Today
FMC (FMC) expects tariff headwinds for Q1 as Q4 earnings slip - MSN
FMC Weighs Full Sale As Debt Pressures And Patent Risks Mount - simplywall.st
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at Bank of America Global Agriculture and Materials Conference - Finviz
FMC (FMC) Expects Tariff Headwinds for Q1 as Q4 Earnings Slip - Finviz
FMC stock price jumps nearly 7% as traders weigh strategic review and fresh Citi target cut - TechStock²
FMC Corp Earnings Call Maps Difficult Transition Year - TipRanks
10 Best High-Upside Materials Stocks to Buy - Insider Monkey
FMC Maintained at Neutral by Citigroup; Price Target Lowered to $14 | FMC Stock News - GuruFocus
Breaking Down FMC: 11 Analysts Share Their Views - Benzinga
FMC price target lowered to $16 from $17 at BofA - TipRanks
FMC’s Strategic Initiatives Promise Debt Reduction and Growth - StocksToTrade
FMC Corp: Chemical Contender Stages a Tentative Rebound as Wall Street Stays Cautious - AD HOC NEWS
FMC Corporation (FMC): A Bull Case Theory - Finviz
FMC Strengthens 2026 Vision with Bold Debt Reduction, Innovation Plans - timothysykes.com
FMC price target lowered to $15.50 from $17 at Morgan Stanley - Yahoo Finance
FMC Corporation (NYSE:FMC) Q4 2025 Earnings Call Transcript - Insider Monkey
FMC Corporation Just Hit the Panic Button—Sale, Spin-Offs, or Shutdown? - Smartkarma
FMC's Price Target Lowered by RBC Capital: Today's Analyst Insig - GuruFocus
Wells Fargo Maintains FMC Rating, Lowers Price Target | FMC Stoc - GuruFocus
UBS Adjusts Price Target on FMC to $14 From $15, Maintains Neutral Rating - marketscreener.com
Morgan Stanley Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $15.5 - 富途牛牛
Morgan Stanley Lowers FMC (NYSE:FMC) Price Target to $15.50 - MarketBeat
Wells Fargo Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $14 - 富途牛牛
BMO Capital Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $15 - 富途牛牛
UBS Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $14 - 富途牛牛
FMC Q4 Earnings Call Highlights - Yahoo Finance
Top 3 Materials Stocks That May Rocket Higher This Month - Benzinga
FMC Board Reviews Sale Options As Valuation Gap And Risks Emerge - Yahoo Finance
Research Alert: CFRA Reiterates Strong Sell Opinion On Shares Of Fmc Corporation - 富途牛牛
FMC Corp. Stock Just Got Cheaper – Is This Quiet Crash Actually a Power Move? - AD HOC NEWS
FMC Corp (FMC) Q4 2025 Earnings Call Highlights: Strategic Moves Amidst Declining Sales - GuruFocus
FMC Corp (FMC) Q4 2025 Earnings Call Highlights: Strategic Moves Amidst Declining Sales By GuruFocus - Investing.com Canada
FMC downgraded to junk status by Moody’s amid patent challenges - Investing.com
FMC Considering Asset Sales or Potential Sale of Company to Reduce Debt - Morningstar
FMC outlines $1B debt reduction and explores sale, projects $3.6B–$3.8B 2026 sales amid strategic review - MSN
Why FMC Corporation Plunged Today - Yahoo Finance
FMC (FMC) Is Up 6.1% After Board Explores Sale Amid Debt Cuts And Pipeline Reset - Yahoo Finance
FMC : Fourth Quarter 2025 Transcript - marketscreener.com
FMC Corp Stock: Deep-Value Chemistry Play Or Value Trap After A Brutal Slide? - AD HOC NEWS
FMC Corp. to explore strategic options, including possible sale - MSN
FMC (FMC) Shares Experience Significant Drop - GuruFocus
FMC Q4 2025 slides: revenue declines as company explores strategic options - Investing.com
Earnings call transcript: FMC Q4 2025 results reveal revenue shortfall By Investing.com - Investing.com India
Chitosan Market to Reach Over US$ 8.6 Billion by 2035 Driven by Green Chemistry Mandates, Pharmaceutical-Grade Demand, and Vegan Fungal Sourcing | Astute Analytica - GlobeNewswire Inc.
Earnings call transcript: FMC Q4 2025 results reveal revenue shortfall - Investing.com
FMC's Q4 Earnings and Revenues Miss Estimates on Lower Prices - Yahoo Finance
FMC Faces Financial Turmoil Amid Strategic Reviews - StocksToTrade
FMC Corp. explores sale following $2.2B loss - The Business Journals
BofA Securities Maintains FMC Corp(FMC.US) With Hold Rating, Maintains Target Price $17 - 富途牛牛
FMC Sets 2026 Priorities and Explores Strategic Options Amid Portfolio Transition - iGrow News
Fmc Corp Stock (FMC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.66%
8.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):